American Picture House issues going-concern warning
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
American Picture House Corp. (APHP) reported $1,220 in revenue and a $349,421 net loss for the nine months ended September 30, 2026, compared with no revenue and a $1,355,022 net loss a year earlier. Net cash used in operating activities was $84,124, versus $325,877. At quarter-end, APHP had no cash, a $1,548,881 working capital deficit and an $8.2 million accumulated deficit; management said these conditions raise substantial doubt about continuing as a going concern.
Under its BECKY 3 agreement, APHP is entitled to a $360,000 senior equity recoupment preference in exchange for 250,000 shares. Options to buy 300,000 shares at $0.20 each had not been issued, and no recoupment had been collected as of the report date. A Labrys standstill is conditioned on paying $114,081.63 by November 20, 2026 to retire a prior note and the forbearance fee. If unpaid, Labrys stated it would convert on November 23 and treat both notes as in default; the January note’s $172,500 principal remained outstanding.
Disclosure controls were ineffective at September 30, 2026 because of previously reported material weaknesses. Remediation remained ongoing and depended in part on obtaining additional capital.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- Moderate pointNine-month net loss declined to $349,421 from $1,355,022.
- Moderate pointNine-month operating cash used declined to $84,124 from $325,877.
Negative
- Major pointGoing-concern warning: $1,548,881 working capital deficit and no cash at quarter-end.
- Major pointDisclosure controls remained ineffective at September 30, 2026 due to material weaknesses.
- Moderate pointScheduled Labrys amortization payments were missed; $172,500 principal remained outstanding. 3% of market cap
Filing Explained
APHP issued additional common shares, reducing existing holders’ ownership percentages; it also applied $875,000 of receivables noncash to film obligations.
On
Separately, during the nine months ended September 30, 2026, APHP applied
The report also states that scheduled amortization payments under the
Key Figures
Key Terms
going concern financial
working capital deficit financial
senior equity recoupment preference financial
cash asset management agreement financial
forbearance fee financial
material weaknesses regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What were APHP’s revenue and net loss for the first nine months of 2026?
What did APHP report about its cash and going-concern status?
What payment is required for APHP’s Labrys standstill?
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
For
the quarterly period ended
COMMISSION
FILE NO.
(Exact name of registrant as specified in its charter)
| 7812 | ||||
| (State or another jurisdiction of incorporation) | (Primary Standard Industrial Classification Code Number) | (I.R.S. Employer Identification No.) |
(Address and telephone number of registrant’s executive office)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| None | N/A | N/A |
Securities registered pursuant to Section 12(g) of the Act: Common Stock
Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days.
Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files).
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. Large accelerated filer ☐ Accelerated filer ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No
As
of November 13, 2026, the Registrant had
AMERICAN PICTURE HOUSE CORPORATION
FORM 10-Q
FOR THE QUARTER ENDED SEPTEMBER 30, 2026
TABLE OF CONTENTS
| GENERAL AND WHERE YOU CAN FIND MORE INFORMATION | 1 |
| PART I FINANCIAL INFORMATION | F-1 |
| ITEM 1. FINANCIAL STATEMENTS (unaudited) | F-1 |
| CONDENSED CONSOLIDATED BALANCE SHEETS – SEPTEMBER 30, 2026 AND DECEMBER 31, 2025 | F-2 |
| CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS – THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025 | F-3 |
| CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT) – THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025 | F-4 |
| CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS – NINE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025 | F-5 |
| NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS | F-6 |
| ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS | 2 |
| ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK | 5 |
| ITEM 4. CONTROLS AND PROCEDURES | 5 |
| PART II OTHER INFORMATION | 6 |
| ITEM 1. LEGAL PROCEEDINGS | 6 |
| ITEM 1A. RISK FACTORS | 6 |
| ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS | 6 |
| ITEM 3. DEFAULTS UPON SENIOR SECURITIES | 7 |
| ITEM 4. MINE SAFETY DISCLOSURES | 7 |
| ITEM 5. OTHER INFORMATION | 7 |
| ITEM 6. EXHIBITS | 7 |
| SIGNATURES | 8 |
GENERAL AND WHERE YOU CAN FIND MORE INFORMATION
Unless otherwise indicated, all references to the “Company,” “we,” “our,” and “APHP” refer to American Picture House Corporation, a Wyoming corporation. References to “revenues” refer to net revenues. References to “U.S. dollars,” “dollars,” “U.S.$” and “$” are to the lawful currency of the United States of America.
| 1 |
PART I - FINANCIAL INFORMATION
Item 1. Financial Statements.
AMERICAN PICTURE HOUSE CORPORATION
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF SEPTEMBER 30, 2026
INDEX TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
| Condensed Consolidated Balance Sheets, September 30, 2026 and December 31, 2025 | F-2 |
| Condensed Consolidated Statements of Operations, for the three and nine months ended September 30, 2026 and 2025 | F-3 |
| Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit), for the three and nine months ended September 30, 2026 and 2025 | F-4 |
| Condensed Consolidated Statements of Cash Flows, for the nine months ended September 30, 2026 and 2025 | F-5 |
| Notes to Condensed Consolidated Financial Statements | F-6 |
| F-1 |
AMERICAN PICTURE HOUSE CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
| September 30, 2026 | December 31, 2025 | |||||||
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash and cash equivalents | $ | - | $ | |||||
| Accounts receivable | ||||||||
| Prepaid expenses | ||||||||
| Receivable - related party | - | - | ||||||
| Total Current Assets | ||||||||
| Produced and licensed content costs | ||||||||
| Loans receivable, film financing arrangements | - | - | ||||||
| Intangible assets, net of accumulated amortization
of $ | ||||||||
| TOTAL ASSETS | ||||||||
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | ||||||||
| Current Liabilities | ||||||||
| Cash overdraft | - | |||||||
| Accounts payable and accrued expenses | ||||||||
| Deferred revenue, current portion | ||||||||
| Interest payable - related party | ||||||||
| Interest payable - EIDL loan | ||||||||
| Interest payable - Notes Payable | - | |||||||
| Note payable | ||||||||
| Note payable - related party | ||||||||
| Note payable | ||||||||
| Commercial Line of Credit | ||||||||
| Total Current Liabilities | ||||||||
| Economic injury disaster loan, non-current | ||||||||
| Total Liabilities | ||||||||
| Stockholders’ Equity (Deficit): | ||||||||
| Common Stock $ | ||||||||
| Preferred Stock $ | - | - | ||||||
| Additional paid in capital | ||||||||
| Accumulated deficit | ( | ) | ( | ) | ||||
| Total Stockholders’ Equity (Deficit) | ( | ) | ( | ) | ||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | $ | $ | ||||||
The accompanying notes are an integral part of these unaudited consolidated financial statements.
| F-2 |
AMERICAN PICTURE HOUSE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| Three months ended September 30, | Nine months ended September 30, | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| Revenues | $ | - | $ | - | $ | $ | - | |||||||||
| Cost of revenues | - | - | - | - | ||||||||||||
| Gross profit | - | - | - | |||||||||||||
| Operating Expenses: | ||||||||||||||||
| General and administrative | ||||||||||||||||
| Research and development | - | - | - | - | ||||||||||||
| Sales and marketing | ||||||||||||||||
| Total Operating Expenses | ||||||||||||||||
| Net Operating Loss | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Other Income (Expenses): | ||||||||||||||||
| Interest income | - | - | - | |||||||||||||
| Interest expense | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Net Other Income (Expenses) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Loss before income taxes | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Income taxes | - | - | - | - | ||||||||||||
| Net loss | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Net loss per common share - Basic and Diluted | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Weighted average shares used in per share computation - Basic and Diluted | ||||||||||||||||
The accompanying notes are an integral part of these unaudited consolidated financial statements.
| F-3 |
AMERICAN PICTURE HOUSE CORPORATION
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)
For the nine months ended September 30, 2026 and 2025
(Unaudited)
| Shares | Par Value | Shares | Amount | Paid In Capital | Accumulated Deficit | Equity (Deficit) | ||||||||||||||||||||||
| Common Stock | Preferred Stock | Additional | Total Stockholders’ | |||||||||||||||||||||||||
| Shares | Par Value | Shares | Amount | Paid In Capital | Accumulated Deficit | Equity (Deficit) | ||||||||||||||||||||||
| Balance, December 31, 2024 | $ | $ | - | $ | $ | ( | ) | $ | ( | ) | ||||||||||||||||||
| Preferred stock redeemed in exchange for assets | - | - | ( | ) | - | ( | ) | - | ( | ) | ||||||||||||||||||
| Stock option compensation | - | - | - | - | - | |||||||||||||||||||||||
| Net Loss | - | - | - | - | - | ( | ) | ( | ) | |||||||||||||||||||
| Balance, March 31, 2025 | $ | $ | - | $ | $ | ( | ) | $ | ( | ) | ||||||||||||||||||
| Common Stock issued for services | - | - | ||||||||||||||||||||||||||
| Stock option compensation | - | - | - | - | - | |||||||||||||||||||||||
| Net Loss | - | - | - | - | - | ( | ) | ( | ) | |||||||||||||||||||
| Balance, June 30, 2025 | $ | $ | - | $ | $ | ( | ) | $ | ( | ) | ||||||||||||||||||
| Stock option compensation | - | - | - | - | - | |||||||||||||||||||||||
| Net Loss | - | - | - | - | - | ( | ) | ( | ) | |||||||||||||||||||
| Balance, September 30, 2025 | $ | $ | - | $ | $ | ( | ) | $ | ( | ) | ||||||||||||||||||
| Common Stock | Preferred Stock | Additional | Total Stockholders’ | |||||||||||||||||||||||||
| Shares | Par Value | Shares | Amount | Paid In Capital | Accumulated Deficit | Equity (Deficit) | ||||||||||||||||||||||
| Balance, December 31, 2025 | $ | $ | - | $ | $ | ( | ) | $ | ( | ) | ||||||||||||||||||
| Financing costs settled in shares of stock | - | - | - | |||||||||||||||||||||||||
| Note payable ($ | - | - | - | |||||||||||||||||||||||||
| Net Loss | - | - | - | - | - | ( | ) | ( | ) | |||||||||||||||||||
| Balance, March 31, 2026 | $ | $ | - | $ | $ | ( | ) | $ | ( | ) | ||||||||||||||||||
| Balance | $ | $ | - | $ | $ | ( | ) | $ | ( | ) | ||||||||||||||||||
| Net Loss | - | - | - | - | - | ( | ) | ( | ) | |||||||||||||||||||
| Balance, June 30, 2026 | $ | $ | - | $ | $ | ( | ) | $ | ( | ) | ||||||||||||||||||
| Issuance of Common Stock | - | - | - | |||||||||||||||||||||||||
| Common stock issued for Licensed Content | - | - | - | |||||||||||||||||||||||||
| Common Stock issued for services | - | - | - | |||||||||||||||||||||||||
| Net Loss | - | - | - | - | - | ( | ) | ( | ) | |||||||||||||||||||
| Balance, September 30, 2026 | $ | $ | - | $ | $ | ( | ) | $ | ( | ) | ||||||||||||||||||
| Balance | $ | $ | - | $ | $ | ( | ) | $ | ( | ) | ||||||||||||||||||
The accompanying notes are an integral part of these unaudited consolidated financial statements.
| F-4 |
AMERICAN PICTURE HOUSE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
| 2026 | 2025 | |||||||
| Nine months ended September 30, | ||||||||
| 2026 | 2025 | |||||||
| Cash Flows from Operating Activities: | ||||||||
| Net Income (Loss) | $ | ( | ) | $ | ( | ) | ||
| Adjustments to Reconcile Net Income (Loss) to Net Cash Flows from Operating Activities: | ||||||||
| Reserve for uncollectible receivable | - | |||||||
| Expiration of produced and licensed costs | - | |||||||
| Stock option expense | - | |||||||
| Common stock issued for services | ||||||||
| Common Stock issued for Produced and Licensed Content | - | |||||||
| Preferred stock redeemed in exchange for assets | - | ( | ) | |||||
| Note payable converted to equity | ( | ) | - | |||||
| Financing costs paid in shares of common stock | - | |||||||
| Amortization expense | ||||||||
| Change in operating assets and liabilities: | ||||||||
| Accounts receivable | ||||||||
| Prepaid expenses | ( | ) | ||||||
| Receivables - related party | - | |||||||
| Loans receivable, film financing arrangements | - | - | ||||||
| Produced and licensed costs | ( | ) | ( | ) | ||||
| Cash overdraft | ( | ) | ||||||
| Accounts payable and accrued expenses | ||||||||
| Interest payable - Notes Payable | - | |||||||
| Interest payable - related parties | ( | ) | ||||||
| Interest payable - EIDL loan | ( | ) | ( | ) | ||||
| Deferred revenue | - | - | ||||||
| Net Cash Flows from Operating Activities | ( | ) | ( | ) | ||||
| Cash Flows from Investing Activities: | ||||||||
| Intangible assets | - | - | ||||||
| Net Cash Flows from Investing Activities | - | - | ||||||
| Cash Flows from Financing Activities: | ||||||||
| Proceeds from issuance of note payable | - | - | ||||||
| Proceeds from debt borrowings - related parties | ||||||||
| Repayment of debt borrowings - related parties | ( | ) | ( | ) | ||||
| Proceeds from commercial line of credit | - | |||||||
| Repayments on commercial line of credit | - | - | ||||||
| Proceeds from note payable | ||||||||
| Repayment of note payable | ( | ) | - | |||||
| Proceeds from sale of Common Stock | - | |||||||
| Net Cash Flows from Financing Activities | ||||||||
| Net Increase in Cash and Cash Equivalents | ( | ) | ||||||
| Cash and Cash Equivalents, Beginning of Period | - | |||||||
| Cash and Cash Equivalents, End of Period | $ | - | $ | |||||
| $ | ||||||||
| Non-cash Financing and Investing Activities: | ||||||||
| Notes payable converted to Common Stock | - | - | ||||||
| Financing costs paid in Common Stock | - | - | ||||||
| Common Stock issued for services | ||||||||
| Common Stock issued for Produced and licensed costs | - | |||||||
The accompanying notes are an integral part of these unaudited interim consolidated financial statements.
| F-5 |
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1 – Organization and Description of Business
American Picture House Corporation (the “Company,” “we,” “APHP,” and “us”) was incorporated in the State of Nevada on September 21, 2005, originally under the corporate name of Servinational, Inc. The Company subsequently changed its name to Shikisai International, Inc. in November 2005 and then to Life Design Station, Intl., Inc. in August 2007. The Company changed its state of domicile from Nevada to Wyoming on October 13, 2020. On December 4, 2020, the Company changed its name to American Picture House Corporation. The Company’s year-end is December 31.
APHP is an entertainment company focused on the development, packaging, financing and production of feature films and limited series. During 2025, the Company pivoted away from third-party consulting to concentrate on internally developed projects and selective strategic partnerships. As of September 30, 2026, APHP’s project participation includes BARRON’S COVE, POSE, THIEVES HIGHWAY, PROTECTOR, MOTION and THE LAST TEMPTATION OF BECKY. BARRON’S COVE, POSE and THIEVES HIGHWAY were released in 2025; PROTECTOR was released in U.S. theaters on March 6, 2026; THE LAST TEMPTATION OF BECKY had its world premiere on July 25, 2026 and was released theatrically on November 4, 2026; MOTION was in post-production as of September 30, 2026.
The Company had no employees as of September 30, 2026 and continued to rely on consultants and other independent contractors for corporate operations and project-level activities.
NOTE 2 – Summary of Significant Accounting Policies
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with U.S. GAAP and pursuant to the rules and regulations of the Securities and Exchange Commission applicable to interim financial statements. In the opinion of management, the interim financial statements include all adjustments of a normal recurring nature necessary for a fair presentation of the interim periods presented. The results for the interim period are not necessarily indicative of the results to be expected for the full year ending December 31, 2026. These unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto for the year ended December 31, 2025.
Principles of Consolidation
The condensed consolidated financial statements include the accounts of American Picture House Corporation and its wholly owned subsidiaries, Devil’s Half-Acre, LLC and Ask Christine Productions, LLC. All intercompany balances and transactions have been eliminated in consolidation. The Company dissolved Devil’s Half-Acre, LLC and Ask Christine Productions, LLC on May 12, 2025.
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the related disclosures of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates.
Cash and Cash Equivalents
Cash equivalents are short-term highly liquid investments with original maturities of three months or less when acquired. Checks issued in excess of available bank balances are classified as a book overdraft within accounts payable and accrued expenses.
Accounts Receivable
Accounts
receivable primarily consist of trade receivables due from customers for consulting services and from fees derived from licensing of
IP to content providers worldwide. As of September 30, 2026, accounts receivable was related to the BUFFALOED CAMA (see Assigned
Rights to feature film, BUFFALOED below) and collection service fees related to the Company’s contractual revenue collection
rights to BARRON’S COVE. As of December 31, 2025,
| F-6 |
There was no bad debt expense for the three and nine months ended September 30, 2026 and 2025 and no additional allowance for doubtful accounts for the periods ended September 30, 2026 and December 31, 2025.
Schedule of Accounts Receivable
Schedule of Accounts Receivable
| September 30, 2026 | December 31, 2025 | |||||||
| Accounts receivable, CAMA | $ | $ | - | |||||
| Accounts receivable, Collection Service Fees | ||||||||
| Accounts receivable | $ | $ | ||||||
Produced and Licensed Content Costs
Capitalized production costs, whether produced or acquired/licensed rights, include development costs, direct costs and production overhead, and are subject to impairment evaluation when events or circumstances indicate the carrying value may not be recoverable. These amounts and licensed content are included in “Produced and Licensed Content Costs” on the balance sheet as follows:
Schedule of Produced and Licensed Content Costs
Schedule of Produced and Licensed Content Costs
| September 30, 2026 | December 31, 2025 | |||||||
| Films in development and pre-production stage | $ | $ | - | |||||
| Films commercially released | $ | $ | ||||||
| Produced and licensed content cost | $ | $ | ||||||
BUFFALOED.
Completed; Released. In November 2022, the Company obtained certain limited rights to the feature film BUFFALOED from Bold Crayon,
Inc. (“BC”), including a secured position of a one million three hundred eighty-thousand-dollar ($
BARRON’S COVE. Completed; Released. APHP acquired a first-priority recoupment/loan position related to this title in August 2025. The film was released in the U.S. on June 6, 2025 by Well Go USA. As reported by the producer/sales agent, a three-year U.S. streaming license with Paramount+ was executed in early October 2025.
BARRON’S
COVE. Revenue collection and inter-party allocation. On December 29, 2025, the Company entered into Amendment No. 1 to its agreement
with SSS Entertainment, LLC (“SSS”), which sets forth inter-party revenue collection and allocation mechanics for amounts
actually received by the Company from exploitation of BARRON’S COVE.
POSE. The Company’s POSE arrangement was restructured pursuant to the Multi-Film Investment and Compensation Agreement with SSS effective January 27, 2026.
THIEVES HIGHWAY. Completed; Released. APHP earned an “In Association With” credit.
| F-7 |
PROTECTOR. Completed; Released. APHP earned an “In Association With” credit; PROTECTOR was released in U.S. theaters on March 6, 2026.
LAST
TEMPTATION OF BECKY. Completed; Released. On May 26, 2026, the Company entered into a Master Investment and Co-Production Agreement
with Becky III The Movie LLC and Russell Posternak (executed June 3, 2026) relating to the motion picture THE LAST TEMPTATION OF BECKY
(referred to in the agreement as “BECKY 3”). Under the agreement, the Company is entitled to a $
MOTION.
In post-production. Pursuant to the Multi-Film Investment and Compensation Agreement with SSS Entertainment, LLC effective January 27,
2026, the Company agreed to provide a $
Intangible assets
The
Company’s intangible assets include in-service and under-development websites and licensed internal use software. The capitalized
costs of the Company’s websites placed into service were subject to straight-line amortization over a three-year period. Amortization
expense totaled $
Deferred Revenue
Deferred
revenue represents the amount billed to clients that has not yet been earned, pursuant to agreements entered into in current and prior
periods. As of September 30, 2026 and December 31, 2025, total net deferred revenue was $
Revenues and Costs from Services and Products
The
Company’s revenue is derived from contracts with customers for consulting services and from the licensing and distribution of film
and other entertainment rights. The Company has elected the ASC 606 “as invoiced” practical expedient with respect to its
consulting services revenue. Revenue from films and licensed rights, including amounts received under cash asset management arrangements,
is recognized when collection is deemed probable; ultimate revenues are estimated over a period not to exceed ten years following the
date of initial release of the motion picture. Cost of revenues includes only those costs directly related to the services rendered.
Revenues totaled $
Fair Value Measurements
The Company measures and discloses fair value in accordance with ASC Topic 820, Fair Value Measurements and Disclosures. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The three-tier fair-value hierarchy prioritizes the inputs used in measuring fair value: Level 1 – unadjusted quoted prices in active markets for identical assets or liabilities; Level 2 – observable inputs other than quoted prices; and Level 3 – unobservable inputs. The carrying value of cash and cash equivalents and all other short-term monetary assets and liabilities are estimated to approximate their fair value due to the short-term nature of these instruments.
| F-8 |
Valuation of Long-Lived Assets
The Company evaluates whether events or circumstances have occurred which indicate that the carrying amounts of long-lived assets (principally produced and licensed content costs) may be impaired or not recoverable, and measures impairment based on the projected discounted cash flows of the asset over its remaining life.
Stock-Based Compensation
The Company follows U.S. GAAP, which requires all stock-based compensation, including the grant of employee stock options, to be recognized in the statement of operations based on its fair value, recognized on a straight-line basis over the service period of each award. Refer to Note 6 for additional information.
Income taxes
The Company accounts for income taxes under FASB ASC 740. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, measured using enacted tax rates. A tax position must be more-likely-than-not to be sustained upon examination for the related benefit to be recognized. The Company assesses its uncertain tax positions quarterly.
Net Loss Per Share
Basic net loss per common share is computed by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Diluted net loss per common share reflects the potential dilution from common stock equivalents only to the extent they are not anti-dilutive. For the three and nine months ended September 30, 2026, potentially dilutive securities included Series A preferred shares and outstanding stock options.
Schedule of Anti-dilutive Securities Excluded from Computation of Weighted Average Common Shares Outstanding
Schedule of Anti-dilutive Securities Excluded from Computation of Weighted Average Common Shares Outstanding
| September 30, 2026 | December 31, 2025 | |||||||
| Convertible Preferred Stock | ||||||||
| Stock options | ||||||||
In
addition to the securities presented above, at September 30, 2026 the Company had outstanding convertible notes payable under which shares
of common stock may be issued upon conversion. Because the conversion price is variable and is determined by reference to the market
price of the Company’s common stock at the time of conversion, the number of shares issuable upon conversion is not determinable
as of the reporting date and has therefore not been included in the table. The Company has reserved an initial
Segment Information
The
Company operates as
Recently Issued Accounting Pronouncements
Management has evaluated recently issued accounting pronouncements through the filing date of this Quarterly Report and determined that none are expected to have a material impact on the Company’s condensed consolidated financial statements.
NOTE 3 – Liquidity and Going Concern
The
accompanying condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern. As
of September 30, 2026, the Company had a working capital deficit of approximately $
Management’s current plan to address these conditions includes continued project monetization efforts, borrowings from related parties or third parties, equity issuances or equity-linked financings, and disciplined management of operating expenditures. There can be no assurance that these efforts will be successful.
| F-9 |
NOTE 4 – Notes Payable
Economic Injury Disaster Loan
The
Company’s EIDL obligation had a carrying value of $
Commercial Line of Credit
The
American Express line of credit balance was $
Convertible note financing (Labrys Fund II)
On
January 20, 2026, the Company entered into a securities purchase agreement with Labrys Fund II, L.P. (“Labrys”) pursuant
to which the Company issued a
During
the nine months ended September 30, 2026, Labrys converted $
During
the quarter ended September 30, 2026, the
The
January 20, 2026 note provides for scheduled amortization payments that commenced July 20, 2026. As of September 30, 2026 and as of
the date of this report, the full principal amount of $
Convertible note financing (Quick Capital, LLC)
On
April 17, 2026, the Company entered into a securities purchase agreement with Quick Capital, LLC (“Quick”) pursuant to
which the Company issued a
There were no conversions under this note during the nine months ended September 30, 2026.
NOTE 5 – Related Party Debt and Interest
Note Payable – Mr. MacGregor
The Company is party to a master loan agreement with Mr. MacGregor, its Chief Executive Officer, under which advances
accrue interest at
Noah Morgan Private Family Trust Loan Agreement (“NMPFT”)
The Company is party to a separate master loan agreement with The Noah Morgan Private Family Trust (“NMPFT”),
a principal stockholder of the Company affiliated with Mr. MacGregor, under which advances accrue interest at
| F-10 |
NOTE 6 – Equity and Stock-Based Compensation
Authorized
Capital. The Company has
Common
and Preferred Shares. As of September 30, 2026 and December 31, 2025, the Company had
Share
Issuances During the Quarter Ended September 30, 2026. On August 6, 2026, the Company issued an aggregate of
Option
grants to SSS Entertainment. The Multi-Film Investment and Compensation Agreement with SSS Entertainment, LLC contemplates the grant
of nonqualified stock options to purchase an aggregate of
Stock
Options. As of September 30, 2026 and December 31, 2025,
| F-11 |
NOTE 7 – Commitments and Contingencies
Legal Proceedings. The Company is the respondent in a consolidated arbitration before JAMS in Los Angeles, California (Ref. No. 5220010741, consolidated with Ref. No. 5220010727), commenced in September 2025 by two entities affiliated with former consultants to the Company and seeking consulting fees claimed to be due under consulting agreements dated May 3, 2024. The Company disputes the claims and has objected to the commencement of the proceedings, service of the demands, the arbitrator appointment process and the consolidation.
On August 18, 2026, Ameriprise Financial, Inc.
filed a complaint in the United States District Court for the District of Massachusetts (Case No. 1:26-cv-13816) against Barron’s
Cove The Film, Inc., the Company and Mr. MacGregor. The complaint alleges that Barron’s Cove The Film, Inc. breached a January 2024
agreement to sell approximately $
The Company has not recorded a liability for these matters because it does not believe that a loss is probable. The Company is unable to estimate the amount or range of any reasonably possible loss in either matter.
Professional
fee discussions (Aldous PLLC). The Company and Aldous PLLC entered into a tolling and standstill agreement effective March 1, 2026
with respect to outstanding professional fees. Draft settlement documentation, including a proposed settlement amount of $
BECKY
3 Master Investment and Co-Production Agreement. Effective May 26, 2026, and executed on June 3, 2026, the Company entered into
a Master Investment and Co-Production Agreement and related ancillary agreements with Russ Posternak and Becky III The Movie LLC
with respect to the motion picture BECKY 3. The Company is not obligated to fund any cash under the agreement. The Company is
treated for economic purposes as having made a $
NOTE 8 – Related Party Transactions
The following is a summary of related party transactions for the three and nine months ended September 30, 2026 and 2025:
CEO salary waiver; standstill on preferred transfers/conversions. On December 31, 2025, Mr. MacGregor, the Company’s Chief Executive Officer and controlling stockholder, delivered a letter to the Company’s Board confirming that he is waiving any cash salary effective January 1, 2025 through March 31, 2026, unless the Board expressly approves otherwise in a written resolution executed after the date of the letter, and confirming a standstill on the sale, transfer, pledge, or conversion of his preferred shares during the same period. Mr. MacGregor has extended the salary waiver and preferred standstill through a date no later than December 31, 2026, which extension was accepted by the Board of Directors on August 13, 2026.
Professional
fees / related party. During the three and nine months ended September 30, 2025, the Company incurred approximately $
| F-12 |
Board
consulting arrangements. During the three months ended September 30, 2026 and 2025, the Company had consulting services relationships
with members of the Board of Directors whereby they were compensated a total of $
Loans / Mr. MacGregor and NMPFT. See Note 5 for related-party note balances and activity.
Director
share purchase. On August 6, 2026, Timothy Battles, a member of the Board of Directors, purchased
Transfers
by principal stockholder. On August 6, 2026, The Noah Morgan Private Family Trust, a principal stockholder of the Company affiliated
with the Company’s Chief Executive Officer, transferred an aggregate of
NOTE 9 – Subsequent Events
Management has evaluated subsequent events through the date these condensed consolidated financial statements are issued.
Labrys
standstill. On October 15 and 19, 2026, Labrys Fund II, L.P. confirmed by email that it will take no action under either of the
Company’s promissory notes held by it, including no conversion, through November 20, 2026, in exchange for the Company’s
payment by that date of the prior promissory note in full ($
| F-13 |
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of our results of operations and financial condition should be read in conjunction with our condensed consolidated financial statements and the notes thereto included elsewhere in this Quarterly Report on Form 10-Q. This discussion contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements for a variety of reasons, including those set forth in our Annual Report on Form 10-K and in other filings with the SEC.
Overview
American Picture House Corporation is an entertainment company focused on the development, packaging, financing and production of feature films and limited series. During 2025, we pivoted away from third-party consulting to concentrate on internally developed projects and selective strategic partnerships. We generally pursue two complementary approaches to participating in projects: (i) structured film finance and senior or priority recoupment positions, including senior secured production lending and first-priority receipt structures designed to prioritize return of capital; and (ii) building an owned or controlled content library over time by acquiring or optioning intellectual properties and, where appropriate, obtaining negative ownership or other control rights in projects.
Recent Developments During the Nine Months Ended September 30, 2026
| ● | On January 20, 2026, we completed a convertible note financing with Labrys Fund II, L.P. for a $150,000 purchase price, including $114,000 of cash proceeds to the Company after specified deductions and offsets, together with a 10% promissory note in the original principal amount of $172,500, 200,000 commitment shares, and an initial 12,000,000-share conversion reserve. | |
| ● | Effective January 27, 2026, we entered into a Multi-Film Investment and Compensation Agreement with SSS Entertainment, LLC that revised our arrangement with respect to POSE, contemplated funding for MOTION, and contemplated an additional investment in an untitled SSS-produced picture, each subject to the terms of the agreement and applicable approvals. | |
| ● | On March 12, 2026, our Board approved entry into the Multi-Film Agreement and ratified Amendment No. 1 to the APHP/SSS Agreement relating to POSE and BARRON’S COVE, effective December 29, 2025. | |
| ● | PROTECTOR was released in U.S. theaters on March 6, 2026. | |
| ● | Effective May 26, 2026, and executed on June 3, 2026, we entered into a Master Investment and Co-Production Agreement, together with related ancillary agreements, with Russ Posternak and Becky III The Movie LLC relating to the motion picture THE LAST TEMPTATION OF BECKY (referred to in the agreement as “BECKY 3”). Under the agreement, we are treated for all economic purposes as having made a $300,000 senior equity investment in the picture without funding any cash, entitling us to recoup 120% of that amount ($360,000) out of the picture waterfall on a senior equity basis, pari passu with up to $300,000 of other senior equity, together with a 10% distribution fee corridor participation, a 10% participation in the producer’s future BECKY-related producer fees and backend, an assignment of certain BARRON’S COVE collateral recovery rights, first look rights on future projects of the producer’s production company, and customary company and individual screen credits. As consideration, we agreed to issue 250,000 shares of common stock and to grant options to purchase 300,000 shares at $0.20 per share. The shares were issued on August 6, 2026. The options had not been issued as of the date of this report. See Note 7 and Note 6 to the condensed consolidated financial statements. | |
| ● | During the nine months ended September 30, 2026, we applied $875,000 of amounts otherwise receivable by us toward our funding obligations under the Multi-Film Agreement, in exchange for content interests relating to MOTION and an untitled SSS-produced picture and in partial satisfaction of amounts payable with respect to POSE. The transaction did not involve the receipt or payment of cash. See Note 2 to the condensed consolidated financial statements and “Liquidity and Capital Resources — Produced and Licensed Content Costs” below. | |
| ● | During the nine months ended September 30, 2026, Labrys Fund II, L.P. converted a portion of its prior promissory note into 162,600 shares of common stock. Scheduled amortization payments under the January 2026 note commenced July 20, 2026. As of the date of this report, the full principal amount of $172,500 of that note remained outstanding. See Note 4 to the condensed consolidated financial statements. |
| ● | The grant of options to purchase an aggregate of 700,000 shares of common stock, at an exercise price of $0.20 per share, to four designees of SSS Entertainment, LLC from the option pool contemplated under the Multi-Film Agreement remains subject to the conditions described in Note 6 to the condensed consolidated financial statements. None of those options had been granted as of the date of this report. |
| 2 |
| ● | On July 25, 2026, THE LAST TEMPTATION OF BECKY had its world premiere at the Fantasia International Film Festival in Montreal. The picture was released theatrically on November 4, 2026 by Quiver Distribution. As of the date of this report, we had collected no amounts in respect of our senior equity recoupment preference. | |
| ● | On August 6, 2026, we issued an aggregate of 930,000 shares of common stock, consisting of 500,000 shares to Timothy Battles, a director, and 100,000 shares to an existing stockholder, in each case at $0.10 per share for cash; 80,000 shares to a consultant to the Company in consideration of services; and 250,000 shares to Russell Posternak pursuant to the Master Investment and Co-Production Agreement. | |
| ● | MOTION is in final post-production; distribution arrangements had not been concluded as of the date of this report. |
Recent Developments Subsequent to September 30, 2026
| ● | On October 15 and 19, 2026, Labrys Fund II, L.P. agreed to a standstill through November 20, 2026 on both of the Company’s notes held by it, conditioned on the Company paying $114,081.63 by that date. See Note 9 to the condensed consolidated financial statements and “Liquidity and Capital Resources” below. | |
| ● | See Note 9 to the condensed consolidated financial statements for additional information regarding events subsequent to September 30, 2026. |
Results of Operations
Three Months Ended September 30, 2026 Compared to Three Months Ended September 30, 2025
The following table summarizes our results of operations for the three months ended September 30, 2026 and 2025:
| Three Months Ended September 30, | ||||||||||||
| 2026 | 2025 | Change $ | ||||||||||
| Revenues | $ | - | $ | - | $ | - | ||||||
| Cost of revenues | - | - | - | |||||||||
| - | - | - | ||||||||||
| Operating Expenses: | ||||||||||||
| General and administrative | 38,240 | 67,743 | (29,503 | ) | ||||||||
| Research and development | - | - | - | |||||||||
| Sales and marketing | 364 | 7,027 | (6,663 | ) | ||||||||
| Total Operating Expenses | 38,604 | 74,770 | (36,166 | ) | ||||||||
| Net Operating Loss | (38,604 | ) | (74,770 | ) | 36,166 | |||||||
| Other Income (Expenses): | ||||||||||||
| Interest income | - | - | - | |||||||||
| Interest expense | (68,120 | ) | (30,787 | ) | (37,333 | ) | ||||||
| Net Other Income (Expenses) | (68,120 | ) | (30,787 | ) | (37,333 | ) | ||||||
| Loss before income taxes | (106,724 | ) | (105,557 | ) | (1,167 | ) | ||||||
| Income taxes | - | - | - | |||||||||
| Net loss | $ | (106,724 | ) | $ | (105,557 | ) | $ | (1,167 | ) | |||
Revenues. The Company had no revenues during the three months ended September 30, 2026 or 2025.
General and Administrative Expenses. General and administrative expenses for the three months ended September 30, 2026 were $38,240, compared with $67,743 for the three months ended September 30, 2025. The decrease of $29,503 reflects management’s efforts to reduce operational spend to conserve cash resources.
Sales and Marketing Expenses. Sales and marketing expenses were $364 for the three months ended September 30, 2026, compared with $7,027 for the comparable prior-year period.
Interest Expense. Interest expense was $68,120 for the three months ended September 30, 2026, compared with $30,787 for the three months ended September 30, 2025.
| 3 |
Nine Months Ended September 30, 2026 Compared to Nine Months Ended September 30, 2025
The following table summarizes our results of operations for the nine months ended September 30, 2026 and 2025:
| Nine Months Ended September 30, | ||||||||||||
| 2026 | 2025 | Change $ | ||||||||||
| Revenues | $ | 1,220 | $ | - | $ | 1,220 | ||||||
| Cost of revenues | - | - | - | |||||||||
| 1,220 | - | 1,220 | ||||||||||
| Operating Expenses: | ||||||||||||
| General and administrative | 207,377 | 1,293,606 | (1,086,229 | ) | ||||||||
| Research and development | - | - | - | |||||||||
| Sales and marketing | 4,150 | 8,857 | (4,707 | ) | ||||||||
| Total Operating Expenses | 211,527 | 1,302,463 | (1,090,936 | ) | ||||||||
| Net Operating Loss | (210,307 | ) | (1,302,463 | ) | 1,092,156 | |||||||
| Other Income (Expenses): | ||||||||||||
| Interest income | - | 44 | (44 | ) | ||||||||
| Interest expense | (139,114 | ) | (52,603 | ) | (86,511 | ) | ||||||
| Net Other Income (Expenses) | (139,114 | ) | (52,559 | ) | (86,555 | ) | ||||||
| Loss before income taxes | (349,421 | ) | (1,355,022 | ) | 1,005,601 | |||||||
| Income taxes | - | - | - | |||||||||
| Net loss | $ | (349,421 | ) | $ | (1,355,022 | ) | $ | 1,005,601 | ||||
Revenues. During the nine months ended September 30, 2026, revenues were $1,220, compared with $0 for the nine months ended September 30, 2025. The change was primarily attributable to income from the BUFFALOED CAMA.
General and Administrative Expenses. General and administrative expenses for the nine months ended September 30, 2026 were $207,377, compared with $1,293,606 for the nine months ended September 30, 2025. The 2025 period included $110,000 of stock-based compensation expense to a consultant, the write-off of $196,200 of loans receivable that management determined were uncollectible, and the expiration of rights to a screenplay carried on the books at $150,834. The 2025 period also included $379,065 of stock option expense compared to $0 in the 2026 period. These one-time expenses were offset by lower operational expenses including a $141,000 reduction in legal and professional fees and a $191,000 reduction in consulting fees
Sales and Marketing Expenses. Sales and marketing expenses for the nine months ended September 30, 2026 were $4,150, compared with $8,857 for the nine months ended September 30, 2025.
Interest Expense. Interest expense for the nine months ended September 30, 2026 was $139,114, compared with $52,603 for the prior-year period, with the change primarily attributable to the Labrys and Quick Capital financings.
Liquidity and Capital Resources
As of September 30, 2026, we had no cash and cash equivalents, a book overdraft of $737 included in accounts payable and accrued expenses, a working capital deficit of $1,548,881, and an accumulated deficit of approximately $8.2 million. These conditions raise substantial doubt about our ability to continue as a going concern.
Operating Activities. During the nine months ended September 30, 2026, net cash used in operating activities was $84,124, compared with net cash used in operating activities of $325,877 for the same 2025 period. The 2026 period reflects $1,028,184 of collections on amounts due under the Company’s BARRON’S COVE revenue collection rights and $875,000 applied toward funding obligations under the Multi-Film Investment and Compensation Agreement.
Investing Activities. The Company had no investing activities during the nine months ended September 30, 2026 and 2025.
| 4 |
Financing Activities. During the nine months ended September 30, 2026, net cash provided by financing activities was $84,000. The 2026 period reflects net proceeds and repayments from promissory notes of $215,250 and $35,542, respectively, and $60,000 of proceeds from the sale of 600,000 shares of common stock. Additionally, during the first nine months of 2026, the Company borrowed and repaid $9,095 and $164,803 under related party notes payable. During the nine months ended September 30, 2025, net cash provided by financing activities was $427,752. The 2025 period reflects $115,000 of proceeds from a promissory note, $331,821 of borrowings and $20,119 of repayments under notes payable to related parties, and $1,050 of borrowings under the commercial line of credit.
Labrys Notes. Under the standstill described in Note 9, we must pay Labrys Fund II, L.P. $114,081.63 by November 20, 2026 to retire the prior promissory note and the forbearance fee; the January 20, 2026 note ($172,500 of principal and $17,250 of accrued interest) will remain outstanding. If the payment is not made, Labrys has stated that it will convert and treat both notes as in default, which would be dilutive to our stockholders and would accelerate our obligations under the notes. We intend to fund the payment from project receipts, advances from related parties or other financing, and there can be no assurance that such funds will be available by November 20, 2026. Labrys has advised that it is not in a position to extend further credit to the Company.
Funding Requirements. We expect our expenses to increase in connection with our ongoing film development and production activities and our public-company reporting obligations. We expect to finance operations and investments through a combination of project receipts, debt financings, equity issuances, and strategic transactions, although there can be no assurance that sufficient capital will be available on acceptable terms, or at all.
Critical Accounting Policies and Estimates
Our management’s discussion and analysis of financial condition and results of operations are based on our condensed consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenues and expenses during the reporting period. We believe our critical accounting policies and estimates include those related to revenue recognition, collectability of receivables, impairment of produced and licensed content costs and intangible assets, stock-based compensation, accounting for debt and equity-linked instruments, and contingencies.
Off-Balance Sheet Arrangements
None, except as may be described in the notes to the condensed consolidated financial statements.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
As a smaller reporting company, we are not required to provide the information otherwise required by this Item.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures. Under the supervision and with the participation of our management, including our Chief Executive Officer and our principal financial officer, we carried out an evaluation of the effectiveness of our disclosure controls and procedures as of September 30, 2026, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934. Based upon that evaluation, our Chief Executive Officer and principal financial officer concluded that our disclosure controls and procedures were not effective as of September 30, 2026, due to the material weaknesses previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2025, consisting of a lack of sufficient internal accounting personnel, a lack of segregation of duties, and a lack of sufficient internal controls (including information technology general controls) encompassing the Company as a whole at the entity and transaction levels to ensure complete documentation of complex and non-routine transactions and adequate financial reporting.
Management has identified corrective actions intended to address these material weaknesses, subject to the availability of financial resources, including engaging additional accounting and finance personnel or third-party accounting resources, enhancing documentation supporting complex and non-routine transactions, and formalizing review procedures over the preparation of periodic reports. Remediation efforts were not complete as of September 30, 2026 and remain ongoing. Because the Company’s ability to implement these measures depends in part on obtaining additional capital, there can be no assurance that such efforts will be successful or that they will fully address the material weaknesses identified.
Changes in Internal Control Over Financial Reporting. There were no changes in our internal control over financial reporting during the quarter ended September 30, 2026 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
| 5 |
PART II - OTHER INFORMATION
Item 1. Legal Proceedings
On September 10 and September 12, 2025, respectively, ACME Film Company, an entity affiliated with Michael Jones, and Joncar Productions, Inc., an entity affiliated with Jonathan Sanger, the Company’s former President, submitted demands for arbitration against the Company to JAMS in Los Angeles, California (JAMS Ref. Nos. 5220010727 and 5220010741). Each demand arises out of a consulting agreement dated May 3, 2024 and seeks payment of consulting fees claimed to be due under that agreement. JAMS consolidated the matters under Ref. No. 5220010741 in December 2025. The Company disputes the claims and has objected to the commencement of the proceedings, the service of the demands, the arbitrator appointment process and the consolidation, reserving all rights, objections and defenses.
On August 18, 2026, Ameriprise Financial, Inc. filed a complaint in the United States District Court for the District of Massachusetts, captioned Ameriprise Financial, Inc. v. Barron’s Cove The Film, Inc., American Picture House Corporation and Bannor MacGregor, Case No. 1:26-cv-13816. The complaint alleges that Barron’s Cove The Film, Inc. breached a January 2024 agreement to sell approximately $1.2 million of Massachusetts film tax credits to the plaintiff, for which the plaintiff alleges it paid $995,507.92. It includes separate claims against the Company and Mr. MacGregor arising out of alleged interference, as to which the complaint seeks injunctive relief relating to the tax credit certificate and damages, including treble damages under M.G.L. c. 93A. On November 10, 2026, the parties filed a joint motion to extend the time for the Company and Mr. MacGregor to answer or otherwise respond to the complaint to December 18, 2026.
Other than the foregoing, there were no material developments during the quarter ended September 30, 2026 in any legal proceeding previously reported, and the Company is not a party to any other material pending legal proceeding.
Item 1A. Risk Factors
As a smaller reporting company, we are not required to provide the information otherwise required by this Item.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Sales During the Quarter Ended September 30, 2026. On August 6, 2026, the Company issued an aggregate of 930,000 shares of common stock in transactions not involving any public offering. Of that amount, 250,000 shares were issued to the producer under the Master Investment and Co-Production Agreement relating to the motion picture THE LAST TEMPTATION OF BECKY as consideration for credits, branding rights and the economic entitlements granted to the Company under that agreement; and 680,000 shares were issued to three holders, consisting of 600,000 shares sold for cash at a price of $0.10 per share for aggregate gross proceeds of $60,000, and 80,000 shares issued as compensation for services rendered to the Company. The Company received $60,000 of gross proceeds, which were used for general working capital purposes, and no underwriting discounts or commissions were paid. The Company received no cash proceeds with respect to the shares issued under THE LAST TEMPTATION OF BECKY agreement or the shares issued for services. All of the securities were issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, and/or Rule 506(b) of Regulation D promulgated thereunder. Each recipient represented that the securities were being acquired for investment and not with a view to distribution, no general solicitation or general advertising was used, and the securities are subject to customary restrictive legends. The shares issued represented less than 1% of the Company’s outstanding common stock. See Note 6 and Note 7 to the condensed consolidated financial statements.
| 6 |
Of the 600,000 shares sold for cash, 500,000 shares were purchased by a member of the Company’s Board of Directors, who is an accredited investor within the meaning of Rule 501(a)(4) of Regulation D by virtue of his position as a director.
Item 3. Defaults Upon Senior Securities
Scheduled amortization payments under the Company’s January 20, 2026 promissory note to Labrys Fund II, L.P. were not made when due. As of the date of this report, the principal amount of $172,500 and accrued interest of $17,250 remained outstanding under that note, and $85,204.35 of principal remained outstanding under a prior note held by Labrys. Labrys has agreed to take no action under either note through November 20, 2026 on the terms described in Note 9 to the condensed consolidated financial statements.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
During the quarter ended September 30, 2026, there were no material changes to the procedures by which security holders may recommend nominees to the Company’s board of directors.
During
the quarter ended September 30, 2026, no director or officer of the Company
Item 6. Exhibits
| Exhibit No. | Description | |
| 31.1 | Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
| 31.2 | Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
| 32.1 | Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350. | |
| 32.2 | Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350. | |
| 101 | Inline XBRL/Interactive Data Files. | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |
| 7 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
AMERICAN PICTURE HOUSE CORPORATION
| Date: November 13, 2026 | By: | /s/ Bannor Michael MacGregor |
| Name: | Bannor Michael MacGregor | |
| Title: | Chief Executive Officer | |
| Date: November 13, 2026 | By: | /s/ Daniel Hirsch |
| Name: | Daniel Hirsch | |
| Title: | Principal Financial Officer / Chief Accounting Officer |
| 8 |